SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-14-004167
Filing Date
2014-08-14
Accepted
2014-08-14 07:43:42
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnib_10q.htm 10-Q 912585
2 CERTIFICATION tnib_ex311.htm EX-31.1 17153
3 CERTIFICATION tnib_ex312.htm EX-31.2 17322
4 CERTIFICATION tnib_ex321.htm EX-32.1 10498
  Complete submission text file 0001354488-14-004167.txt   3006558

Data Files

Seq Description Document Type Size
5 tnib-20140630.xml EX-101.INS 311320
6 tnib-20140630.xsd EX-101.SCH 33280
7 tnib-20140630_cal.xml EX-101.CAL 33354
8 tnib-20140630_def.xml EX-101.DEF 34882
9 tnib-20140630_lab.xml EX-101.LAB 178939
10 tnib-20140630_pre.xml EX-101.PRE 113999
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
TNI BIOTECH, INC. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 141039474
SIC: 2834 Pharmaceutical Preparations